APA (7th ed.) Citation

Jain, N. A., Lu, K., Ito, S., Muranski, P., Hourigan, C. S., Haggerty, J., . . . Barrett, A. J. (2014). The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation—implications for preventative treatment approaches. Cytotherapy (Oxford, England), 16(7), 927-933. https://doi.org/10.1016/j.jcyt.2014.02.010

Chicago Style (17th ed.) Citation

Jain, Natasha A., et al. "The Clinical and Financial Burden of Pre-emptive Management Of cytomegalovirus Disease After Allogeneic Stem Cell Transplantation—implications for Preventative Treatment Approaches." Cytotherapy (Oxford, England) 16, no. 7 (2014): 927-933. https://doi.org/10.1016/j.jcyt.2014.02.010.

MLA (9th ed.) Citation

Jain, Natasha A., et al. "The Clinical and Financial Burden of Pre-emptive Management Of cytomegalovirus Disease After Allogeneic Stem Cell Transplantation—implications for Preventative Treatment Approaches." Cytotherapy (Oxford, England), vol. 16, no. 7, 2014, pp. 927-933, https://doi.org/10.1016/j.jcyt.2014.02.010.